2023-2029 Global Genital Herpes Vaccine Industry Research & Trends Analysis Report
According to YH Research, the global market for Genital Herpes Vaccine should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Genital Herpes Vaccine market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Genital Herpes Vaccine market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Zoster Vaccine Live segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Male has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Genital Herpes Vaccine include GSK, Merck, BioNTech, Beike Bio and Changsheng Biotechnology, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Genital Herpes Vaccine. Report Highlights:
(1) Global Genital Herpes Vaccine market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Genital Herpes Vaccine market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Genital Herpes Vaccine market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Genital Herpes Vaccine segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Genital Herpes Vaccine segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Genital Herpes Vaccine, capacity, production and trends.
(7) Genital Herpes Vaccine industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Zoster Vaccine Live
Recombinant Zoster Vaccine
Market segment by application, can be divided into
Male
Female
Market segment by players, this report covers
GSK
Merck
BioNTech
Beike Bio
Changsheng Biotechnology
1 Market Overview
1.1 Genital Herpes Vaccine Definition
1.2 Global Genital Herpes Vaccine Market Size and Forecast
1.2.1 By Revenue, Global Genital Herpes Vaccine Market Size, 2018-2029
1.2.2 By Sales Volume, Global Genital Herpes Vaccine Market Size, 2018-2029
1.2.3 Global Genital Herpes Vaccine Price Trend, 2018-2029
1.3 China Genital Herpes Vaccine Market Size and Forecast
1.3.1 By Revenue, China Genital Herpes Vaccine Market Size, 2018-2029
1.3.2 By Sales Volume, China Genital Herpes Vaccine Market Size, 2018-2029
1.3.3 China Genital Herpes Vaccine Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Genital Herpes Vaccine Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Genital Herpes Vaccine Share in Global Market, 2018-2029
1.4.3 Genital Herpes Vaccine Market Size: China VS Global, 2018-2029
1.5 Genital Herpes Vaccine Market Dynamics
1.5.1 Genital Herpes Vaccine Market Drivers
1.5.2 Genital Herpes Vaccine Market Restraints
1.5.3 Genital Herpes Vaccine Industry Trends
1.5.4 Genital Herpes Vaccine Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Genital Herpes Vaccine Revenue by Company, 2018-2023
2.2 Global Genital Herpes Vaccine Sales Volume by Company, 2018-2023
2.3 Global Genital Herpes Vaccine Price by Company, 2018-2023
2.4 Global Genital Herpes Vaccine Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Genital Herpes Vaccine Concentration Ratio
2.6 Global Genital Herpes Vaccine Mergers & Acquisitions, Expansion Plans
2.7 Global Genital Herpes Vaccine Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Genital Herpes Vaccine Revenue by Company, 2018-2023
3.2 China Genital Herpes Vaccine Sales Volume by Company, 2018-2023
3.3 China Genital Herpes Vaccine Genital Herpes Vaccine Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Genital Herpes Vaccine Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Genital Herpes Vaccine Domestic VS Export
3.6 China Market, Genital Herpes Vaccine Import & Export
3.6.1 China Market, Genital Herpes Vaccine Import & Export, 2018-2029
3.6.2 China Genital Herpes Vaccine Import & Export Trends
3.6.3 Main Sources of China Genital Herpes Vaccine Import
3.6.4 Export Destination of China Genital Herpes Vaccine
4 Genital Herpes Vaccine Production by Region
4.1 Global Genital Herpes Vaccine Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Genital Herpes Vaccine Manufacturers
4.3 Global Major Manufacturers, Genital Herpes Vaccine Capacity Expansion and Future Plans
4.4 Global Genital Herpes Vaccine Capacity by Region
4.5 Global Genital Herpes Vaccine Production by Region
4.5.1 Global Genital Herpes Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Genital Herpes Vaccine Production by Region, 2018-2023
4.5.3 Global Genital Herpes Vaccine Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Genital Herpes Vaccine Industry Chain
5.2 Genital Herpes Vaccine Upstream Analysis
5.2.1 Genital Herpes Vaccine Core Raw Materials
5.2.2 Main Manufacturers of Genital Herpes Vaccine Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Genital Herpes Vaccine Production Mode
5.6 Genital Herpes Vaccine Procurement Model
5.7 Genital Herpes Vaccine Industry Sales Model and Sales Channels
5.7.1 Genital Herpes Vaccine Sales Model
5.7.2 Genital Herpes Vaccine Typical Distributors
6 Sights by Type
6.1 Genital Herpes Vaccine Classification
6.1.1 Zoster Vaccine Live
6.1.2 Recombinant Zoster Vaccine
6.2 By Type, Global Genital Herpes Vaccine Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Genital Herpes Vaccine Revenue, 2018-2029
6.4 By Type, Global Genital Herpes Vaccine Sales Volume, 2018-2029
6.5 By Type, Global Genital Herpes Vaccine Price, 2018-2029
7 Sights by Application
7.1 Genital Herpes Vaccine Segment by Application
7.1.1 Male
7.1.2 Female
7.2 By Application, Global Genital Herpes Vaccine Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Genital Herpes Vaccine Revenue, 2018-2029
7.4 By Application, Global Genital Herpes Vaccine Sales Volume, 2018-2029
7.5 By Application, Global Genital Herpes Vaccine Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Genital Herpes Vaccine Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Genital Herpes Vaccine Revenue, 2018-2029
8.3 By Region, Global Genital Herpes Vaccine Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Genital Herpes Vaccine Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Genital Herpes Vaccine Market Size Market Share
8.5 Europe
8.5.1 Europe Genital Herpes Vaccine Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Genital Herpes Vaccine Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Genital Herpes Vaccine Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Genital Herpes Vaccine Market Size Market Share
8.7 South America
8.7.1 South America Genital Herpes Vaccine Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Genital Herpes Vaccine Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Genital Herpes Vaccine Market Size & CAGR，2018 VS 2022 VS 2029
9.2 By Country, Global Genital Herpes Vaccine Revenue, 2018-2029
9.3 By Country, Global Genital Herpes Vaccine Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Genital Herpes Vaccine Market Size, 2018-2029
9.4.2 By Company, U.S. Genital Herpes Vaccine Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Genital Herpes Vaccine Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Genital Herpes Vaccine Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Genital Herpes Vaccine Market Size, 2018-2029
9.5.2 By Company, Europe Genital Herpes Vaccine Sales Volume Market Share, 2022
9.5.3 By Type, Europe Genital Herpes Vaccine Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Genital Herpes Vaccine Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Genital Herpes Vaccine Market Size, 2018-2029
9.6.2 By Company, China Genital Herpes Vaccine Sales Volume Market Share, 2022
9.6.3 By Type, China Genital Herpes Vaccine Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Genital Herpes Vaccine Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Genital Herpes Vaccine Market Size, 2018-2029
9.7.2 By Company, Japan Genital Herpes Vaccine Sales Volume Market Share, 2022
9.7.3 By Type, Japan Genital Herpes Vaccine Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Genital Herpes Vaccine Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Genital Herpes Vaccine Market Size, 2018-2029
9.8.2 By Company, South Korea Genital Herpes Vaccine Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Genital Herpes Vaccine Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Genital Herpes Vaccine Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Genital Herpes Vaccine Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Genital Herpes Vaccine Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Genital Herpes Vaccine Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Genital Herpes Vaccine Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Genital Herpes Vaccine Market Size, 2018-2029
9.10.2 By Company, India Genital Herpes Vaccine Sales Volume Market Share, 2022
9.10.3 By Type, India Genital Herpes Vaccine Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Genital Herpes Vaccine Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Genital Herpes Vaccine Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Genital Herpes Vaccine Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Genital Herpes Vaccine Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Genital Herpes Vaccine Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 GSK
10.1.1 GSK Company Information, Head Office, Market Area and Industry Position
10.1.2 GSK Genital Herpes Vaccine Models, Specifications and Application
10.1.3 GSK Genital Herpes Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 GSK Company Profile and Main Business
10.1.5 GSK Recent Developments
10.2 Merck
10.2.1 Merck Company Information, Head Office, Market Area and Industry Position
10.2.2 Merck Genital Herpes Vaccine Models, Specifications and Application
10.2.3 Merck Genital Herpes Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Merck Company Profile and Main Business
10.2.5 Merck Recent Developments
10.3 BioNTech
10.3.1 BioNTech Company Information, Head Office, Market Area and Industry Position
10.3.2 BioNTech Genital Herpes Vaccine Models, Specifications and Application
10.3.3 BioNTech Genital Herpes Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 BioNTech Company Profile and Main Business
10.3.5 BioNTech Recent Developments
10.4 Beike Bio
10.4.1 Beike Bio Company Information, Head Office, Market Area and Industry Position
10.4.2 Beike Bio Genital Herpes Vaccine Models, Specifications and Application
10.4.3 Beike Bio Genital Herpes Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Beike Bio Company Profile and Main Business
10.4.5 Beike Bio Recent Developments
10.5 Changsheng Biotechnology
10.5.1 Changsheng Biotechnology Company Information, Head Office, Market Area and Industry Position
10.5.2 Changsheng Biotechnology Genital Herpes Vaccine Models, Specifications and Application
10.5.3 Changsheng Biotechnology Genital Herpes Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Changsheng Biotechnology Company Profile and Main Business
10.5.5 Changsheng Biotechnology Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables and Figures
Table 1. Genital Herpes Vaccine Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Genital Herpes Vaccine Market Restraints
Table 3. Genital Herpes Vaccine Market Trends
Table 4. Genital Herpes Vaccine Industry Policy
Table 5. Global Genital Herpes Vaccine Revenue by Company, 2018-2023, US$ million
Table 6. Global Genital Herpes Vaccine Revenue Market Share by Company, 2018-2023
Table 7. Global Genital Herpes Vaccine Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Genital Herpes Vaccine Sales Volume Market Share by Company, 2018-2023
Table 9. Global Genital Herpes Vaccine Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Genital Herpes Vaccine Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Genital Herpes Vaccine Mergers & Acquisitions, Expansion Plans
Table 12. Global Genital Herpes Vaccine Manufacturers Product Type
Table 13. China Genital Herpes Vaccine Revenue by Company, 2018-2023, US$ million
Table 14. China Genital Herpes Vaccine Revenue Market Share by Company, 2018-2023
Table 15. China Genital Herpes Vaccine Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Genital Herpes Vaccine Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Genital Herpes Vaccine Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Genital Herpes Vaccine Import & Export Trends
Table 19. Main Sources of China Genital Herpes Vaccine Import
Table 20. Export Destination of China Genital Herpes Vaccine
Table 21. Global Headquarters and Manufacturing Base of Genital Herpes Vaccine Manufacturers
Table 22. Global Major Manufacturers, Genital Herpes Vaccine Capacity Expansion and Future Plans
Table 23. Global Genital Herpes Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Genital Herpes Vaccine Production by Region, 2018-2023, (K Units)
Table 25. Global Genital Herpes Vaccine Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Genital Herpes Vaccine Upstream (Raw Materials)
Table 27. Global Genital Herpes Vaccine Typical Customers
Table 28. Genital Herpes Vaccine Typical Distributors
Table 29. By Type, Global Genital Herpes Vaccine Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Genital Herpes Vaccine Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Genital Herpes Vaccine Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Genital Herpes Vaccine Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Genital Herpes Vaccine Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Genital Herpes Vaccine Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Genital Herpes Vaccine Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Genital Herpes Vaccine Revenue Market Share, 2018-2029
Table 37. By Country, Global Genital Herpes Vaccine Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Genital Herpes Vaccine Sales Volume Market Share, 2018-2029
Table 39. GSK Company Information, Head Office, Market Area and Industry Position
Table 40. GSK Genital Herpes Vaccine Models, Specifications and Application
Table 41. GSK Genital Herpes Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. GSK Company Profile and Main Business
Table 43. GSK Recent Developments
Table 44. Merck Company Information, Head Office, Market Area and Industry Position
Table 45. Merck Genital Herpes Vaccine Models, Specifications and Application
Table 46. Merck Genital Herpes Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Merck Company Profile and Main Business
Table 48. Merck Recent Developments
Table 49. BioNTech Company Information, Head Office, Market Area and Industry Position
Table 50. BioNTech Genital Herpes Vaccine Models, Specifications and Application
Table 51. BioNTech Genital Herpes Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. BioNTech Company Profile and Main Business
Table 53. BioNTech Recent Developments
Table 54. Beike Bio Company Information, Head Office, Market Area and Industry Position
Table 55. Beike Bio Genital Herpes Vaccine Models, Specifications and Application
Table 56. Beike Bio Genital Herpes Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Beike Bio Company Profile and Main Business
Table 58. Beike Bio Recent Developments
Table 59. Changsheng Biotechnology Company Information, Head Office, Market Area and Industry Position
Table 60. Changsheng Biotechnology Genital Herpes Vaccine Models, Specifications and Application
Table 61. Changsheng Biotechnology Genital Herpes Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Changsheng Biotechnology Company Profile and Main Business
Table 63. Changsheng Biotechnology Recent Developments
List of Figure
Figure 1. Genital Herpes Vaccine Picture
Figure 2. By Revenue, Global Genital Herpes Vaccine Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Genital Herpes Vaccine Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Genital Herpes Vaccine Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Genital Herpes Vaccine Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Genital Herpes Vaccine Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Genital Herpes Vaccine Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Genital Herpes Vaccine Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Genital Herpes Vaccine Share of Global Market, 2018-2029
Figure 10. Global Genital Herpes Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Genital Herpes Vaccine Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Genital Herpes Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Genital Herpes Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Genital Herpes Vaccine Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Genital Herpes Vaccine Domestic VS Export, 2022
Figure 16. Global Genital Herpes Vaccine Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Genital Herpes Vaccine Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Genital Herpes Vaccine Production Market Share & Forecast by Region, 2018-2029
Figure 19. Genital Herpes Vaccine Industry Chain
Figure 20. Genital Herpes Vaccine Procurement Model
Figure 21. Genital Herpes Vaccine Sales Model
Figure 22. Genital Herpes Vaccine Sales Channels, Direct Sales and Distribution
Figure 23. Zoster Vaccine Live
Figure 24. Recombinant Zoster Vaccine
Figure 25. By Type, Global Genital Herpes Vaccine Revenue, 2018-2029, US$ Million
Figure 26. By Type, Global Genital Herpes Vaccine Revenue Market Share, 2018-2029
Figure 27. By Type, Global Genital Herpes Vaccine Sales Volume, 2018-2029, (K Units)
Figure 28. By Type, Global Genital Herpes Vaccine Sales Volume Market Share, 2018-2029
Figure 29. By Type, Global Genital Herpes Vaccine Price, 2018-2029, (US$/Unit)
Figure 30. Male
Figure 31. Female
Figure 32. By Application, Global Genital Herpes Vaccine Revenue, 2018-2029, US$ Million
Figure 33. By Application, Global Genital Herpes Vaccine Revenue Market Share, 2018-2029
Figure 34. By Application, Global Genital Herpes Vaccine Sales Volume, 2018-2029, (K Units)
Figure 35. By Application, Global Genital Herpes Vaccine Sales Volume Market Share, 2018-2029
Figure 36. By Application, Global Genital Herpes Vaccine Price, 2018-2029, (US$/Unit)
Figure 37. By Region, Global Genital Herpes Vaccine Revenue Market Share, 2018-2029
Figure 38. By Region, Global Genital Herpes Vaccine Sales Volume Market Share, 2018-2029
Figure 39. North America Genital Herpes Vaccine Revenue & Forecasts, 2018-2029, US$ Million
Figure 40. By Country, North America Genital Herpes Vaccine Revenue Market Share, 2022
Figure 41. Europe Genital Herpes Vaccine Revenue & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, Europe Genital Herpes Vaccine Revenue Market Share, 2022
Figure 43. Asia Pacific Genital Herpes Vaccine Revenue & Forecasts, 2018-2029, US$ Million
Figure 44. By Country/Region, Asia Pacific Genital Herpes Vaccine Revenue Market Share, 2022
Figure 45. South America Genital Herpes Vaccine Revenue & Forecasts, 2018-2029, US$ Million
Figure 46. By Country, South America Genital Herpes Vaccine Revenue Market Share, 2022
Figure 47. Middle East & Africa Genital Herpes Vaccine Revenue & Forecasts, 2018-2029, US$ Million
Figure 48. U.S. Genital Herpes Vaccine Sales Volume, 2018-2029, (K Units)
Figure 49. By Company, U.S. Genital Herpes Vaccine Market Share, 2022
Figure 50. By Type, U.S. Genital Herpes Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 51. By Application, U.S. Genital Herpes Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 52. Europe Genital Herpes Vaccine Sales Volume, 2018-2029, (K Units)
Figure 53. By Company, Europe Genital Herpes Vaccine Market Share, 2022
Figure 54. By Type, Europe Genital Herpes Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 55. By Application, Europe Genital Herpes Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 56. China Genital Herpes Vaccine Sales Volume, 2018-2029, (K Units)
Figure 57. By Company, China Genital Herpes Vaccine Market Share, 2022
Figure 58. By Type, China Genital Herpes Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 59. By Application, China Genital Herpes Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 60. Japan Genital Herpes Vaccine Sales Volume, 2018-2029, (K Units)
Figure 61. By Company, Japan Genital Herpes Vaccine Market Share, 2022
Figure 62. By Type, Japan Genital Herpes Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 63. By Application, Japan Genital Herpes Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 64. South Korea Genital Herpes Vaccine Sales Volume, 2018-2029, (K Units)
Figure 65. By Company, South Korea Genital Herpes Vaccine Market Share, 2022
Figure 66. By Type, South Korea Genital Herpes Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 67. By Application, South Korea Genital Herpes Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 68. Southeast Asia Genital Herpes Vaccine Sales Volume, 2018-2029, (K Units)
Figure 69. By Company, Southeast Asia Genital Herpes Vaccine Market Share, 2022
Figure 70. By Type, Southeast Asia Genital Herpes Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 71. By Application, Southeast Asia Genital Herpes Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 72. India Genital Herpes Vaccine Sales Volume, 2018-2029, (K Units)
Figure 73. By Company, India Genital Herpes Vaccine Market Share, 2022
Figure 74. By Type, India Genital Herpes Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 75. By Application, India Genital Herpes Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 76. Middle East & Asia Genital Herpes Vaccine Sales Volume, 2018-2029, (K Units)
Figure 77. By Company, Middle East & Asia Genital Herpes Vaccine Market Share, 2022
Figure 78. By Type, Middle East & Asia Genital Herpes Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 79. By Application, Middle East & Asia Genital Herpes Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 80. Research Methodology
Figure 81. Breakdown of Primary Interviews
Figure 82. Bottom-up Approaches
Figure 83. Top-down Approaches
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets